Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae

International Journal of Urology

Volumn 15, Issue 9, 2008, Pages 837-842

  Muratani, Tetsuro ^a,b   Inatomi, Hisato ^b,c   Ando, Yukiko ^b,d   Kawai, Shuichi ^b,e   Akasaka, Soichiro ^a,b   Matsumoto, Tetsuro ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Asian Clinical Research Group   (Japan)

^c Department of Neurosurgery   (Japan)

^d Ando Ladies Clinic   (Japan)

^e Kawai Urological Clinic   (Japan)

Author keywords

Clinical trial; Neisseria gonorrhoeae; Penicillin binding protein; Pharyngeal infection; Single dose 1 g ceftriaxone

Indexed keywords

AMPICILLIN; AZITHROMYCIN; AZTREONAM; CEFCAPENE; CEFDINIR; CEFEPIME; CEFIXIME; CEFMENOXIME; CEFMETAZOLE; CEFODIZIME; CEFOXITIN; CEFOZOPRAN; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; FLOMOXEF; LEVOFLOXACIN; MINOCYCLINE; PENICILLIN BINDING PROTEIN; PENICILLIN G; SPECTINOMYCIN; SULTAMICILLIN; TELITHROMYCIN; TETRACYCLINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; PHARYNX DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SINGLE DRUG DOSE; URETHRITIS; UROGENITAL TRACT INFECTION; UTERINE CERVICITIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; FEMALE; GONORRHEA; HUMANS; MALE; MIDDLE AGED; PHARYNGEAL DISEASES; URETHRITIS; UTERINE CERVICITIS; YOUNG ADULT;

EID: 51349130594     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02100.x     Document Type: Article

References (16)

1. Shigemura K, Okada H, Shirakawa T et al. Susceptibilities of neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan. Sex. Transm. Infect. 2004 80 : 105 7.
2. Ito M, Yasuda M, Yokoi S et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob. Agents Chemother. 2004 48 : 3185 7.
3. Muratani T, Akasaka S, Kobayashi T et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob. Agents Chemother. 2001 45 : 3603 6.
4. Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob. Agents Chemother. 2005 49 : 137 43.
5. Matsumoto T, Muratani T, Takahashi K et al. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis. J. Infect. Chemother. 2006 12 : 97 9.
6. The Japanese Society for Sexually Transmitted Diseases. The diagnosis and therapeutic guidelines 2006 for sexually transmitted disease - Neisseria gonorrhoeae. Jpn. J. Sex. Transm. Dis. 2006 Suppl 35 9.
7. Matsumoto T, Muratani T, Takahashi K et al. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection. J. Infect. Chemother. 2006 12 : 145 7.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth Informational Supplement M100-S17 vol. 27 No. 1 : 124 5.
9. Struelens MJ, Rost F, Deplano A et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 1993 95 : 489 98.
10. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol. 1995 33 : 2233 9.
11. Deguchi T, Yasuda M, Yokoi S et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J. Infect. Chemother. 2003 9 : 35 9.
12. Ameyama S, Onodera S, Takahata M et al. Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 2000 46 : 3744 9.
13. Takahata S, Senju N, Osaki Y, Yoshida T, Ida T. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 2006 50 : 3638 45.
14. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin. Infect. Dis. 1995 20 (Suppl 1 S47 65.
15. Ichigi Y, Sagiyama K, Hara S. Single-dose injection of ceftriaxone in male gonorrhoeal urethritis. Chemotherapy 1990 38 : 68 73.
16. Center for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR Morb. Mortal. Wkly Rep. August 4, 2006 55 : No. RR-11, 42 49.